azomycin has been researched along with ascorbic acid in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Josephy, PD; Palcic, B; Skarsgard, LD | 1 |
| Begg, E; O'Shea, K; Wade, D; Williams, K | 1 |
| Rauth, AM; Taylor, YC | 1 |
| Budni, P; Colepicolo, P; Dalmarco, EM; Farias, MS; Filho, DW; Fröde, TS; Oliveira-Silva, D; Parisotto, EB; Pedrosa, RC; Ribeiro, CM | 1 |
| Fortes Francisco, A; Kelly, JM; Lewis, MD; Taylor, MC; Wilkinson, SR | 1 |
| Camargo, RS; Carneiro, ZA; de Albuquerque, S; do Vale, GT; Portapilla, GB; Providello, MV; Tirapelli, CR | 1 |
| Batlle, A; Demaria, A; Frank, FM; Lombardo, ME; Puente, V | 1 |
| Breynaert, A; De Bruyne, T; Hermans, N; Huits, R; Truyens, C; Van Den Broucke, S; Van Esbroeck, M; Van Herreweghe, M | 1 |
8 other study(ies) available for azomycin and ascorbic acid
| Article | Year |
|---|---|
Ascorbate-enhanced cytotoxicity of misonidazole.
Topics: Ascorbic Acid; Cell Line; Drug Synergism; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents | 1978 |
Effects of phenytoin, phenobarbital, and ascorbic acid on misonidazole elimination.
Topics: Adult; Ascorbic Acid; Drug Interactions; Female; Humans; Kinetics; Male; Misonidazole; Nitroimidazoles; Phenobarbital; Phenytoin; Protein Binding | 1983 |
Sulphydryls, ascorbate and oxygen as modifiers of the toxicity and metabolism of misonidazole in vitro.
Topics: Animals; Ascorbic Acid; Cell Line; Cell Survival; Cricetinae; Cricetulus; Cysteamine; Female; Glutathione; HeLa Cells; Humans; Misonidazole; Nitroimidazoles; Ovary; Oxygen; Time Factors | 1980 |
Antioxidant therapy attenuates oxidative insult caused by benzonidazole in chronic Chagas' heart disease.
Topics: Antioxidants; Ascorbic Acid; Chagas Disease; Chronic Disease; Humans; Nitroimidazoles; Oxidative Stress; Thiobarbituric Acid Reactive Substances; Vitamin E | 2010 |
The Trypanosoma cruzi vitamin C dependent peroxidase confers protection against oxidative stress but is not a determinant of virulence.
Topics: Animals; Ascorbic Acid; Endoplasmic Reticulum; Gene Deletion; Gene Expression Regulation, Enzymologic; Hydrogen Peroxide; Luminescent Measurements; Mice; Nitroimidazoles; Oxidative Stress; Peroxidases; Trypanocidal Agents; Trypanosoma cruzi; Virulence | 2015 |
Benefits of Ascorbic Acid in Association with Low-Dose Benznidazole in Treatment of Chagas Disease.
Topics: Animals; Antioxidants; Ascorbic Acid; Chagas Disease; Drug Therapy, Combination; Inflammation; Lipid Peroxidation; Male; Mice; Nitroimidazoles; Oxidation-Reduction; Reactive Oxygen Species; Trypanocidal Agents; Trypanosoma cruzi | 2018 |
Anti-parasitic effect of vitamin C alone and in combination with benznidazole against Trypanosoma cruzi.
Topics: Animals; Ascorbic Acid; Body Weight; Chagas Disease; Chlorocebus aethiops; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Female; Mice, Inbred C3H; Nitroimidazoles; Parasite Load; Parasitemia; Survival Analysis; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi; Vero Cells | 2018 |
Mitigation of benznidazole toxicity and oxidative stress following ascorbic acid supplementation in an adult traveller with chronic indeterminate Chagas' disease.
Topics: Adult; Antioxidants; Ascorbic Acid; Biomarkers; Chagas Disease; Dietary Supplements; Drug-Related Side Effects and Adverse Reactions; Humans; Nitroimidazoles; Oxidative Stress | 2022 |